The association between cagL and cagA, vacAs-m, babA genes in patients with gastric cancer, duodenal ulcer, and non-ulcer dyspepsia related to Helicobacter pylori.


Journal

Acta gastro-enterologica Belgica
ISSN: 1784-3227
Titre abrégé: Acta Gastroenterol Belg
Pays: Belgium
ID NLM: 0414075

Informations de publication

Date de publication:
Historique:
entrez: 23 10 2020
pubmed: 24 10 2020
medline: 30 10 2020
Statut: ppublish

Résumé

As a component of the cag T4SS, the cagL gene is involved in the translocation of CagA into host cells and is essential for the formation of cag PAI-associated pili between H. pylori and gastric epithelial cells. We aimed to investigate the clinical association of the cagL gene with other virulence factors (VacA, CagA, EPIYA-C, and BabA protein) of H. pylori strains isolated from GC, duodenal ulcer (DU), and non-ulcer dyspepsia (NUD) cases. The patient group (PG), including 47 patients (22 GC and 25 DU) and a 25 control group (CG= NUD) were included. Amplification of the H. pylori cagL, cagA, vacA, and babA2 genes and typing of EPIYA motifs were performed by PCR methods. Sixty-one (84.7%) H. pylori strains were detected with cagL (93.6% in SG, 68% in CG). We detected a significant difference between SG and CG for the presence of cagL (p=0.012) but no statistical comparison was done for (≥2) EPIYA-C repeats In the comparison of H. pylori strains with cagA/vacAs1m1 and cagA/ vacAs1m2 and babA2 for the presence of cagL, we could not detect a significant difference (p=1). We detected a significant difference between groups for the presence of cagL genotype (p=0.012). The vacAs1m1 (OR: 2.829), genotypes increased the GC and DU risk by 2.8 times, while multiple (≥2) EPIYA-C repeats incresed the GC and DU risk by 3.524 times. Gender (to be female) (OR: 0.454) decreased the GC and DU risk by inversly decreased in the multivariate analysis.

Identifiants

pubmed: 33094584

Substances chimiques

Antigens, Bacterial 0
Bacterial Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

385-392

Informations de copyright

© Acta Gastro-Enterologica Belgica.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest

Auteurs

S Demiryas (S)

Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of General Surgery, Istanbul, Turkey.

R Caliskan (R)

Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Medical Microbiology, Istanbul, Turkey.

S Saribas (S)

Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Medical Microbiology, Istanbul, Turkey.

S Akkus (S)

Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Medical Microbiology, Istanbul, Turkey.

N Gareayaghi (N)

Istanbul Sisli Hamidiye Etfal Training and Research Hospital, Blood Center, University of Health Sciences, Istanbul, Turkey.

S Kirmusaoglu (S)

T.C. Haliç University, Faculty of Arts and Sciences, Department of Molecular Biology and Genetics, Istanbul, Turkey.

N Kepil (N)

Istanbul University- Cerrahpasa, Cerrahpasa Medical Faculty, Department of Pathology, Istanbul, Turkey.

H Dinc (H)

Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Medical Microbiology, Istanbul, Turkey.

H Dag (H)

Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey.

E Dagdeviren (E)

Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey.

H B Tokman (HB)

Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Medical Microbiology, Istanbul, Turkey.

F Kalayci (F)

Istanbul Yeni Yuzyil University, Medical Faculty, Department of Medical Microbiology, Istanbul, Turkey.

M Demirci (M)

Beykent University Medical Faculty, Department of Medical Microbiology, Istanbul, Turkey.

I Tasci (I)

Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of General Surgery, Istanbul, Turkey.

Y Erzin (Y)

Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Gastroenterology, Istanbul, Turkey.

K Bal (K)

Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Gastroenterology, Istanbul, Turkey.

B Kocazeybek (B)

Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Medical Microbiology, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH